Shares of RHI Magnesita (LON:RHIM - Get Free Report) dropped 1.1% on Wednesday . The stock traded as low as GBX 2,984.99 ($40.74) and last traded at GBX 3,016.69 ($41.17). Approximately 18,805 shares were traded during trading, a decline of 60% from the average daily volume of 47,279 shares. The stock had previously closed at GBX 3,050 ($41.63).
RHI Magnesita Trading Up 0.7%
The firm has a market capitalization of £1.73 billion, a price-to-earnings ratio of 9.53, a PEG ratio of 2.03 and a beta of 1.53. The business's 50-day simple moving average is GBX 2,948.04 and its two-hundred day simple moving average is GBX 3,193.34. The company has a quick ratio of 0.93, a current ratio of 1.91 and a debt-to-equity ratio of 152.96.
RHI Magnesita Company Profile
(
Get Free Report)
RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 22,000 employees in 47 main production sites, 9 recycling facilities and more than 70 sales offices.
Further Reading
Before you consider RHI Magnesita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHI Magnesita wasn't on the list.
While RHI Magnesita currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.